256
Participants
Start Date
January 17, 2018
Primary Completion Date
October 8, 2021
Study Completion Date
October 8, 2021
Olaparib
Patients will be administered olaparib orally, twice daily at 300 mg. Two (2) 150 mg olaparib tablets should be taken at the same time each morning and evening of every day, approximately 12 hours apart.
Research Site, Taoyuan
Research Site, Budapest
Research Site, Budapest
Research Site, Sofia
Research Site, Dresden
Research Site, Sofia
Research Site, Plovdiv
Research Site, Varna
Research Site, Cáceres
Research Site, Taipei
Research Site, Candiolo
Research Site, Goyang-si
Research Site, Taipei
Research Site, Marseille
Research Site, Seongnam
Research Site, Caen
Research Site, Genova
Research Site, Granada
Research Site, Rostock
Research Site, Rozzano
Research Site, Milan
Research Site, Towson
Research Site, Incheon
Research Site, Plerin SUR MER
Research Site, Besançon
Research Site, Madrid
Research Site, Madrid
Research Site, Majadahonda
Research Site, Hanover
Research Site, Pamplona
Research Site, Toulouse
Research Site, Bordeaux
Research Site, Aviano
Research Site, Mersin
Research Site, Montpellier
Research Site, Istanbul
Research Site, Rennes
Research Site, Padua
Research Site, Izmir
Research Site, Vigo
Research Site, Kayseri
Research Site, San Cristóbal de La Laguna
Research Site, Jackson
Research Site, Bologna
Research Site, Taichung
Research Site, Seville
Research Site, Seville
Research Site, Daegu
Research Site, Konya
Research Site, Nantes
Research Site, Saint-Herblain
Research Site, Essen
Research Site, Essen
Research Site, Münster
Research Site, Angers
Research Site, Zaragoza
Research Site, Cologne
Research Site, Nancy
Research Site, Lorient
Research Site, Lille
Research Site, Prato
Research Site, Tekirdağ
Research Site, Pierre-Bénite
Research Site, Le Mans
Research Site, Paris
Research Site, Paris
Research Site, Rouen
Research Site, Napoli
Research Site, München
Research Site, Kaohsiung City
Research Site, München
Research Site, Avignon
Research Site, Limoges
Research Site, Erlangen
Research Site, Catania
Research Site, Moscow
Research Site, Saint Petersburg
Research Site, Saint Petersburg
Research Site, Ryazan
Research Site, Kazan'
Research Site, Samara
Research Site, Ufa
Research Site, Surgut
Research Site, Omsk
Research Site, Irkutsk
Research Site, Vancouver
Research Site, Toronto
Research Site, Québec
Research Site, Saint-Quentin
Research Site, Perugia
Research Site, Roma
Research Site, Roma
Research Site, Roma
Research Site, Nagoya
Research Site, Shinagawa-ku
Research Site, Suita-shi
Research Site, Gdansk
Research Site, Gliwice
Research Site, Grzepnica
Research Site, Lublin
Research Site, Poznan
Research Site, Szczecin
Research Site, Warsaw
Research Site, Wroclaw
Research Site, Seoul
Research Site, Seoul
Research Site, Seoul
Research Site, Alicante
Research Site, Barcelona
Research Site, L'Hospitalet de Llobregat
Research Site, Madrid
Research Site, Adana
Research Site, Adana
Research Site, Ankara
Research Site, Cardiff
Research Site, Colchester
Research Site, Edinburgh
Research Site, Glasgow
Research Site, Leeds
Research Site, London
Research Site, London
Research Site, Manchester
Research Site, Sutton
Lead Sponsor
AstraZeneca
INDUSTRY